BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 2224437)

  • 1. Persistent carcinoma in situ of the testis after chemotherapy for advanced testicular germ cell tumours.
    Bottomley D; Fisher C; Hendry WF; Horwich A
    Br J Urol; 1990 Oct; 66(4):420-4. PubMed ID: 2224437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of the contralateral testis in patients with testicular germ cell cancer.
    Fordham MV; Mason MD; Blackmore C; Hendry WF; Horwich A
    Br J Urol; 1990 Mar; 65(3):290-3. PubMed ID: 2337749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testis conserving chemotherapy in germ cell cancer: its potential to increase understanding of the biology and treatment of carcinoma-in-situ.
    Oliver RT; Ong J; Berney D; Nargund V; Badenoch D; Shamash J
    APMIS; 2003 Jan; 111(1):86-91; discussion 91-2. PubMed ID: 12752243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bilateral and synchronous testicular teratoma: a case report and literature review].
    Matabuena-Tamez P; Canepa-Fernández P; Valencia-García LC; Gutiérrez-Samperio C; Gallegos-Corona MA
    Cir Cir; 2015; 83(6):527-31. PubMed ID: 26164135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sperm concentration, testicular volume and age predict risk of carcinoma in situ in contralateral testis of men with testicular germ cell cancer.
    Rud CN; Daugaard G; Rajpert-De Meyts E; Skakkebæk NE; Petersen JH; Jørgensen N
    J Urol; 2013 Dec; 190(6):2074-80. PubMed ID: 23770148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgery following chemotherapy for metastatic testicular teratoma.
    Whillis D; Coleman RE; Lessells AM; Hargreave TB; Cornbleet MA; Howard GC
    Br J Urol; 1991 Sep; 68(3):292-5. PubMed ID: 1913071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients.
    von der Maase H; Rørth M; Walbom-Jørgensen S; Sørensen BL; Christophersen IS; Hald T; Jacobsen GK; Berthelsen JG; Skakkebaek NE
    Br Med J (Clin Res Ed); 1986 Nov; 293(6559):1398-401. PubMed ID: 3026550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis.
    Amato RJ; Ro JY; Ayala AG; Swanson DA
    Urology; 2004 Jan; 63(1):144-8; discussion 148-9. PubMed ID: 14751368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoma in situ of the testis followed by an overt malignant teratoma of the testis within 12 months.
    Mark SD; Gowland SP; Arnold EP; McRae CU; Fitzharris BM
    Aust N Z J Surg; 1994 Dec; 64(12):862-4. PubMed ID: 7980264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orchiectomy after chemotherapy in patients with metastatic testicular cancer. Is it indicated?
    Simmonds PD; Mead GM; Lee AH; Theaker JM; Dewbury K; Smart CJ
    Cancer; 1995 Feb; 75(4):1018-24. PubMed ID: 7842403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The synchronous appearance of multiple testicular epidermoid cysts and of a malignant mixed germinal tumor in the contralateral testis].
    Stark L; Potratz D; Schäfer R; von Vietsch H
    Urologe A; 1992 Mar; 31(2):85-7. PubMed ID: 1314002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of contralateral testicular intraepithelial neoplasia in patients with testicular germ-cell tumor.
    Dieckmann KP; Loy V
    World J Urol; 1994; 12(3):131-5. PubMed ID: 7951338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial orchidectomy for malignancy with consideration of carcinoma in situ.
    Hughes PD
    ANZ J Surg; 2006; 76(1-2):92-4. PubMed ID: 16483305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current issues in the management of clinical stage I testicular teratoma.
    Horwich A
    Eur J Cancer; 1993; 29A(7):933-4. PubMed ID: 8499143
    [No Abstract]   [Full Text] [Related]  

  • 15. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoma in situ of the testis: review of biological and clinical features.
    Dieckmann KP; Skakkebaek NE
    Int J Cancer; 1999 Dec; 83(6):815-22. PubMed ID: 10597201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chemotherapy on carcinoma in situ of the testis.
    Christensen TB; Daugaard G; Geertsen PF; von der Maase H
    Ann Oncol; 1998 Jun; 9(6):657-60. PubMed ID: 9681081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival after an antiangiogenetic therapy and surgery in a wide spread growing teratoma originating from a testicular mixed malignant germ cell tumor.
    Calaminus G; Schneider DT; Weissbach L; Schönberger S; Okpanyi V; Leuschner I; Poremba C; Göbel U
    Klin Padiatr; 2009; 221(3):136-40. PubMed ID: 19437360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy of testicular cancer: 10-year experience.
    Ondrus D; Hornák M; Matoska J; Kausitz J; Belan V; Cársky S
    Neoplasma; 1993; 40(4):247-53. PubMed ID: 7505886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is organ saving surgery of testicular tumor justified?].
    Weissbach L
    Urologe A; 1993 Jan; 32(1):49-52. PubMed ID: 8383368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.